-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROCRINE BIOSCIENCES INITIATES PHASE 2 CLINICAL STUDY EVALUATING NBI-'567 IN ADULTS WITH ALZHEIMER'S DISEASE

Reuters·10/20/2026 12:30:02

Please log in to view news